- Home
- HROW vs SCS Comparison
HROW vs SCS Comparison
Compare HROW & SCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- SCS
- Stock Information
- Founded
- HROW 1998
- SCS 1912
- Country
- HROW United States
- SCS United States
- Employees
- HROW N/A
- SCS N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- SCS Office Equipment/Supplies/Services
- Sector
- HROW Health Care
- SCS Consumer Discretionary
- Exchange
- HROW Nasdaq
- SCS Nasdaq
- Market Cap
- HROW 1.1B
- SCS 1.2B
- IPO Year
- HROW N/A
- SCS 1998
- Fundamental
- Price
- HROW $34.93
- SCS $10.65
- Analyst Decision
- HROW Strong Buy
- SCS Buy
- Analyst Count
- HROW 7
- SCS 1
- Target Price
- HROW $61.83
- SCS $16.00
- AVG Volume (30 Days)
- HROW 368.3K
- SCS 1.2M
- Earning Date
- HROW 08-06-2025
- SCS 06-25-2025
- Dividend Yield
- HROW N/A
- SCS 3.78%
- EPS Growth
- HROW N/A
- SCS 37.12
- EPS
- HROW N/A
- SCS 1.04
- Revenue
- HROW $212,858,000.00
- SCS $3,217,700,000.00
- Revenue This Year
- HROW $44.89
- SCS $4.20
- Revenue Next Year
- HROW $38.22
- SCS $4.09
- P/E Ratio
- HROW N/A
- SCS $10.18
- Revenue Growth
- HROW 53.49
- SCS 2.64
- 52 Week Low
- HROW $20.85
- SCS $9.32
- 52 Week High
- HROW $59.23
- SCS $14.74
- Technical
- Relative Strength Index (RSI)
- HROW 70.24
- SCS 50.37
- Support Level
- HROW $30.81
- SCS $10.58
- Resistance Level
- HROW $33.27
- SCS $10.99
- Average True Range (ATR)
- HROW 1.37
- SCS 0.43
- MACD
- HROW 0.09
- SCS -0.01
- Stochastic Oscillator
- HROW 88.78
- SCS 56.18
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About SCS Steelcase Inc.
Steelcase Inc is a furniture company based in the United States. Its brands, such as Steelcase, AMQ, Coalesse, Designtex, and others, offer a portfolio of furniture and architectural products and services designed to help customers create workplaces. It markets its products and services to businesses and organizations predominantly through a network of dealers and also sells to consumers in markets around the world through web-based and retail distribution channels. The company's reportable segments include the Americas, which generates key revenue, and the International segment.